- Conditions
- Thromboembolism, Venous
- Interventions
- enoxaparin
- Drug
- Lead sponsor
- Methodist Health System
- Other
- Eligibility
- 18 Years to 120 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Sep 5, 2023 · Synced May 22, 2026, 4:13 AM EDT